SPC
ADAP

Sigma Planning Corp’s Adaptimmune Therapeutics ADAP Stock Holding History

Sigma Planning Corp’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,209
Closed -$43K – 1356
2021
Q2 		$43K Buy
+10,209
New +$43K ﹤0.01% 1376